Literature DB >> 27819686

Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation.

J Sugita1, T Miyamoto2, N Kawashima3, N Hatsumi4, N Anzai5, H Kaneko6, M Nara7, K Minauchi8, M Harada9, T Teshima1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27819686     DOI： 10.1038/bmt.2016.278

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning.

Authors:  Kavita Raj; Antonio Pagliuca; Kenneth Bradstock; Victor Noriega; Victoria Potter; Matthew Streetly; Donal McLornan; Majid Kazmi; Judith Marsh; John Kwan; Gillian Huang; Lisa Getzendaner; Stephanie Lee; Katherine A Guthrie; Ghulam J Mufti; Paul O'Donnell
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-18       Impact factor: 5.742

2.  Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.

Authors:  Alessandra Roberto; Luca Castagna; Veronica Zanon; Stefania Bramanti; Roberto Crocchiolo; James E McLaren; Sara Gandolfi; Paolo Tentorio; Barbara Sarina; Inna Timofeeva; Armando Santoro; Carmelo Carlo-Stella; Benedetto Bruno; Cristiana Carniti; Paolo Corradini; Emma Gostick; Kristin Ladell; David A Price; Mario Roederer; Domenico Mavilio; Enrico Lugli
Journal:  Blood       Date:  2015-03-05       Impact factor: 22.113

3.  Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.

Authors:  Seitaro Terakura; Yoshiko Atsuta; Nobuhiro Tsukada; Takeshi Kobayashi; Masatsugu Tanaka; Junya Kanda; Yuho Najima; Takahiro Fukuda; Naoyuki Uchida; Satoshi Takahashi; Tokiko Nagamura-Inoue; Yasuo Morishima; Koichi Miyamura
Journal:  Biol Blood Marrow Transplant       Date:  2015-10-22       Impact factor: 5.742

4.  Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.

Authors:  Scott R Solomon; Connie A Sizemore; Melissa Sanacore; Xu Zhang; Stacey Brown; H Kent Holland; Lawrence E Morris; Asad Bashey
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-19       Impact factor: 5.742

Review 5.  Cyclophosphamide and cancer: golden anniversary.

Authors:  Ashkan Emadi; Richard J Jones; Robert A Brodsky
Journal:  Nat Rev Clin Oncol       Date:  2009-09-29       Impact factor: 66.675

6.  Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.

Authors:  Yoshiko Atsuta; Ritsuro Suzuki; Tokiko Nagamura-Inoue; Shuichi Taniguchi; Satoshi Takahashi; Shunro Kai; Hisashi Sakamaki; Yasushi Kouzai; Masaharu Kasai; Takahiro Fukuda; Hiroshi Azuma; Minoko Takanashi; Shinichiro Okamoto; Masahiro Tsuchida; Keisei Kawa; Yasuo Morishima; Yoshihisa Kodera; Shunichi Kato
Journal:  Blood       Date:  2008-12-22       Impact factor: 22.113

Review 7.  Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease.

Authors:  Ahmad Samer Al-Homsi; Tara S Roy; Kelli Cole; Yuxin Feng; Ulrich Duffner
Journal:  Biol Blood Marrow Transplant       Date:  2014-08-23       Impact factor: 5.742

8.  Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation.

Authors:  J Tischer; N Engel; S Fritsch; D Prevalsek; M Hubmann; C Schulz; A K Zoellner; V Bücklein; S Lippl; R Reibke; C T Rieger; G Ledderose; H J Stemmler; W Hiddemann; C Schmid; A Hausmann
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

9.  Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

Authors:  Anna Maria Raiola; Alida Dominietto; Anna Ghiso; Carmen Di Grazia; Teresa Lamparelli; Francesca Gualandi; Stefania Bregante; Maria Teresa Van Lint; Simona Geroldi; Silvia Luchetti; Filippo Ballerini; Maurizio Miglino; Riccardo Varaldo; Andrea Bacigalupo
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-29       Impact factor: 5.742

10.  Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.

Authors:  L Castagna; S Bramanti; S Furst; L Giordano; R Crocchiolo; B Sarina; E Mauro; L Morabito; R Bouabdallah; D Coso; M Balzarotti; F Broussais; J El-Cheikh; C C Stella; E Brusamolino; D Blaise; A Santoro
Journal:  Bone Marrow Transplant       Date:  2014-09-15       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.